Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Hypnion
company
About
Hypnion is a neuroscience drug discovery company.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $47.50M
- Industries
- Biotechnology,Health Diagnostics,Medical,Therapeutics
- Founded date
- Jan 1, 2000
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Hypnion is a neuroscience drug discovery and development company that develops novel therapeutics for the treatment of central nervous system disorders. The company develops treatments for sleep- and wake-alertness disorders and circadian rhythm abnormalities.Hypnion offers SCORE-2004, a drug discovery platform that is able to measure drugs’ impact on sleep and wake parameters.Hypnion is acquired by Eli Lilly and Company.Hypnion was founded in 2000 and is based in Worcester, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$47.50M
Hypnion has raised a total of
$47.50M
in funding over 2 rounds. Their latest funding was raised on
Mar 17, 2003 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 17, 2003 | Series B | $47.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Hypnion is funded by 1 investors.
Coastview Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
